Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Retained Earnings: 2022-2025

Historic Retained Earnings for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -$1.4 billion.

  • Gossamer Bio's Retained Earnings fell 12.64% to -$1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 billion, marking a year-over-year decrease of 12.64%. This contributed to the annual value of -$1.3 billion for FY2024, which is 4.66% down from last year.
  • As of Q3 2025, Gossamer Bio's Retained Earnings stood at -$1.4 billion, which was down 3.59% from -$1.3 billion recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Retained Earnings registered a high of -$860.6 million during Q1 2022, and its lowest value of -$1.4 billion during Q3 2025.
  • Its 3-year average for Retained Earnings is -$1.2 billion, with a median of -$1.2 billion in 2024.
  • Data for Gossamer Bio's Retained Earnings shows a maximum YoY decreased of 25.65% (in 2023) over the last 5 years.
  • Over the past 4 years, Gossamer Bio's Retained Earnings (Quarterly) stood at -$1.0 billion in 2022, then fell by 17.42% to -$1.2 billion in 2023, then declined by 4.66% to -$1.3 billion in 2024, then decreased by 12.64% to -$1.4 billion in 2025.
  • Its last three reported values are -$1.4 billion in Q3 2025, -$1.3 billion for Q2 2025, and -$1.3 billion during Q1 2025.